CAS: 53-73-6; (2-(2,4-Diamino-4-Oxobutanamido)-5-((Diaminomethylene)Amino)Pentanoyl)Valyltyrosylvalylhistidylprolylphenylalanine

该化合物是一种在静脉-扬基腾辛系统中起着重要作用的,对调节身体的血压和液体平衡至关重要.它来自血管抑制器二型血管,它参与各种生理过程,包括调节血管音和刺激肾上腺素分泌.血管纳米素的特征是它能够影响心血管功能和液态.就其化学结构而言,它由一系列氨基酸组成,有助于其生物活动.该物质通常在高血压和心脏衰竭的情况下研究,因为它能够影响血压调节机制.它的药理特性使它成为心血管研究的一个主题,尽管它不是通常用作治疗剂.了解其特性对于探索医学和药理学的潜在应用至关重要.

结构式图片

MSDS等安全信息

    上下游产品

    Fm°C-Val-OH Fm°C-Pro-OH N-Fm°C L-Phe Fm°C-Tyr(tBu)-OH6-(p-chlorophenyl)-3-chloropyridazine

    合成工艺路线路线简述

      📜Galactosamine Pentaacetate置于三氟甲磺酸三甲基硅酯体系中,化学反应生成 血管紧张素胺
      参考文献:Composition And Method For Inhibiting Angiotensinogen (Agt) Protein Expression
      标题:Composition And Method For Inhibiting Angiotensinogen (Agt) Protein Expression
      摘要:Provided Are A Composition And Method For Inhibiting Angiotensinogen (Agt) Protein Expression. Specifically,Provided Are A Composition And Method Capable Of Being Used For Reducing Agt Gene Expression And Treating Agt-Related Diseases And Disorders. Provided Are An Agt Dsrna Reagent Capable Of Being Used For Reducing Agt Expression In A Cell And An Object,An Agt Antisense Polynucleotide Reagent,A Composition Containing The Agt Dsrna Reagent,And A Composition Containing The Agt Antisense Polynucleotide Reagent.

      海关参考信息

      专利信息


      专利号:US-2023183223-A1
      优先权日:2020-05-14
      标题:Process for the synthesis of n-butyloxycarbonyl-3-(4-imidazol-1- ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide
      发明人:CERNAKS DMITRIJS; DEGE ELIZA
      权利人:VICORE PHARMA AB
      摘要:There is provided a new process for the synthesis of compounds of formula I, which are useful as angiotensin (Ang II) type 2 receptor agonists: by reacting a compound of formula II, with an excess of a compound of formula III, wherein W, Z and X have meanings given in the description; followed by reaction of the intermediate so formed with a suitable source of the counter-ion, W.

      专利号:US-10925977-B2
      优先权日:2006-10-05
      标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
      发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
      权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
      摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

      专利号:EP-2103609-A1
      优先权日:2008-03-20
      标 题:Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
      权利人:LEK PHARMACEUTICALS
      摘要:One embodiment disclosed in the invention is the efficient synthesis of halogenated biaryl starting material via Grignard chemistry and the use thereof. Another embodiment of the invention is the reaction of catalyzed carbonylation of the 3'-(2'-halo-biphenyl-4-ylmethyl)-1,7'-dimethyl-2'-propyl-1H,3'H-[2,5']bibenzoimidazolyl (TLMH) using either gaseous carbon monoxide in a solvent mixture containing water; or formic acid salts optionally together with acetic acid in anhydrous solvent.

      专利号:US-6717007-B1
      优先权日:1999-09-16
      标 题:Regiospecific synthesis of phosphonous acids
      发明人:DUBEY SUSHIL KUMAR; RAJGOPAL VENKAT; SINGH ANIL VIR; LAHIRI SASWATA; WANI MUKESH JAGANNATH
      权利人:LUPIN LTD
      摘要:An improved regiospecific synthesis of organic phosphonous acids, comprising of hydrophosphorylation of an olefin with hydrophosphorous acid in the presence of an inorganic persulfate, which acts as a source of free radicals at a pH ranging from 4.5 to 7.0, in which the orientation of addition is anti-Markonikoff. The process enables production of organic phosphonous acids at lower temperature and atmospheric pressure under milder pH conditions for better regioselectivity in hydrophosphorylation and obtain the phosphonous acid with good yield and purity following simple isolation procedure. Phosphonous acids obtained by the process are commercially valuable as effective detergents and wetting agents, lubricants and lubricant additives, plasticizers for plastics and resins, corrosion inhibitors, chemicals including insecticides and pesticides, cobalt extractants and as key intermediates for preparation of commercially important angiotensin converting enzyme (ACE) inhibitors.

      专利号:US-6069248-A
      优先权日:1998-08-21
      标题 :Process for the synthesis of triazolopyridazine compounds
      发明人:BOLDI ARMEN M; JOHNSON CHARLES R
      权利人:AXYS PHARM INC
      摘要:The present invention provides a process for the synthesis of triazolopyridazine based compounds represented by Formula A: ##STR1## These compounds have utility as angiotensin related antihypertensive agents.

      专利号:WO-9614060-A1
      优先权日:1994-11-04
      标题 :Use of receptor agonists to stimulate superoxide dismutase activity
      发明人:MARKLUND STEFAN L; STRAALIN PONTUS
      权利人:MARKLUND STEFAN L; STRAALIN PONTUS
      摘要:The present invention relates to the use of a substance for the manufacture of a composition for stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells. In particular, the invention relates to the use of a substance for the manufacture of a composition for prophylaxis or treatment of a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical. Further, the invention relates to a method for determining the effect of a substance with respect to stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells and to substances which have been selected by said method. Within the scope of the invention is a method of preventing, diminishing, controlling or inhibiting a disease or disorder connected with the presence or formation of superoxide radicals and other toxic intermediates derived from the superoxide radical in a patient who has been established to have a high risk of developing a such disease or disorder, or who has developed a such disease or disorder, the method comprising administering an effective amount of a substance which is capable of stimulating the release of EC-SOD from cells or stimulating the synthesis of EC-SOD in cells.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Lee HW, Lim HJ, Jun JH, Choi J, Lee MS. Ginseng for Treating Hypertension: A Systematic Review and Meta-Analysis of Double Blind, Randomized, Placebo-Controlled Trials. Curr Vasc Pharmacol. 2017;15(6):549-556. doi: 10.2174/1570161115666170713092701. Review. doi: 10.1002/jbio.201700044. Epub 2017 Jul 31. doi: 10.1021/acschemneuro.7b00007. Epub 2017 May 9. doi: 10.1016/j.freeradbiomed.2017.04.027. Epub 2017 Apr 21. doi: 10.1016/bs.acc.2016.11.003. Epub 2016 Dec 28. doi: 10.1155/2017/9645874. Epub 2017 Mar 5.
      7: Karpińska O, Baranowska-Kuczko M, Kloza M, Ambroz Ewicz E, Kozłowski T, Kasacka I, Malinowska B, Kozłowska H. Activation of CB(1) receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries. Am J Physiol Regul Integr Comp Physiol. 2017 Jun 1;312(6):R883-R893. doi: 10.1152/ajpregu.00324.2016. Epub 2017 Mar 29. doi: 10.1371/journal.pone.0173611. eCollection 2017.
      9: Ohmori KH, Ooya T, Takeuchi T. Crosslinked Network with Rotatable Binding Sites Based on Monocarboxylated α-Cyclodextrin [2]Rotaxane Capable of Angiotensin III Recognition. Chemistry. 2017 Apr 3;23(19):4708-4712. doi: 10.1002/chem.201700206. Epub 2017 Mar 16. doi: 10.1016/j.jpba.2016.05.049. Epub 2016 Jun 1. doi: CliCa1603399404. Review. Japanese. doi: 10.1016/j.ejphar.2016.01.004. Epub 2016 Jan 22. doi: 10.1016/j.jstrokecerebrovasdis.2015.08.001. Epub 2015 Sep 2. doi: 10.1177/1074248415591700. Epub 2015 Jun 30.

      合成参考文献


      参考文献:10.1007/s10072-010-0218-4
      摘要:Fröhlich I, Pilloy W, Vaillant M, Diederich NJ. Myocardial MIBG scintigraphy: a useful clinical tool : A retrospective study in 50 parkinsonian patients. Neurol Sci. 2010 Jun;31(3):403–6. doi: 10.1007/s10072-010-0218-4.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知